Daily life without cranial bone protection while awaiting cranioplasty: a qualitative study
Acta Neurochirurgica · 09.08.2024 · 166 (1)
DOI: 10.1007/s00701-024-06217-5 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift Acta Neurochirurgica, online erschienen am 09.08.2024. Verfasst von Henrietta Gustavsson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Neurosurgery, Uppsala University, Uppsala, Sweden. henrietta.gustavsson@akademiska.se. Hauptthemen laut MEDLINE: Decompressive Craniectomy, Qualitative Research, Skull. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Uppsala, Uppsala University.
Abstract (Originalsprache)
Purpose
Decompressive craniectomy is occasionally performed as a life-saving neurosurgical intervention in patients with acute severe brain injury to reduce refractory intracranial hypertension. Subsequently, cranioplasty (CP) is performed to repair the skull defect. In the meantime, patients are living without cranial bone protection, and little is known about their daily life. This study accordingly explored daily life among patients living without cranial bone protection after decompressive craniectomy while awaiting CP.
Methods
A multiple-case study examined six purposively sampled patients, patients’ family members, and healthcare staff. The participants were interviewed and the data were analyzed using qualitative content analysis.
Results
The cross-case analysis identified five categories: “Adapting to new ways of living,” “Constant awareness of the absence of cranial bone protection,” “Managing daily life requires available staff with adequate qualifications,” “Impact of daily life depends on the degree of recovery,” and “Daily life stuck in limbo while awaiting cranioplasty.” The patients living without cranial bone protection coped with daily life by developing new habits and routines, but the absence of cranial bone protection also entailed inconveniences and limitations, particularly among the patients with greater independence in their everyday living. Time spent awaiting CP was experienced as being in limbo, and uncertainty regarding planning was perceived as frustrating.
Conclusion
The results indicate a vulnerable group of patients with brain damage and communication impairments struggling to find new routines during a waiting period experienced as being in limbo. Making this period safe and reducing some problems in daily life for those living without cranial bone protection calls for a person-centered approach to care involving providing contact information for the correct healthcare institution and individually planned scheduling for CP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Neurosurgery, Uppsala University, Uppsala, Sweden. henrietta.gustavsson@akademiska.se.
- Uppsala University Hospital, Entrance 85, NIVA, 751 85, Uppsala, Sweden. henrietta.gustavsson@akademiska.se.
- Department of Surgical Sciences, Nursing Research, Uppsala University, Uppsala, Sweden.
- Department of Medical Sciences, Neurosurgery, Uppsala University, Uppsala, Sweden.
ORCID-Profile: Henrietta Gustavsson
Förderung
- Region Uppsala
- Uppsala University
Zitieren
APA
Gustavsson, H., Jangland, E., & Nyholm, L. (2024). Daily life without cranial bone protection while awaiting cranioplasty: a qualitative study. Acta Neurochirurgica, 166(1). https://doi.org/10.1007/s00701-024-06217-5
Vancouver
Gustavsson H, Jangland E, Nyholm L. Daily life without cranial bone protection while awaiting cranioplasty: a qualitative study. Acta Neurochirurgica. 2024;166(1). doi:10.1007/s00701-024-06217-5
BibTeX
@article{Gustavsson2024,
author = {Gustavsson, Henrietta and Jangland, Eva and Nyholm, Lena},
title = {Daily life without cranial bone protection while awaiting cranioplasty: a qualitative study},
journal = {Acta Neurochirurgica},
year = {2024},
volume = {166},
number = {1},
doi = {10.1007/s00701-024-06217-5}
}
EUVIMED